Junto Capital Management LP bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 784,736 shares of the company's stock, valued at approximately $92,811,000. Cardinal Health makes up about 1.8% of Junto Capital Management LP's investment portfolio, making the stock its 20th largest position. Junto Capital Management LP owned approximately 0.32% of Cardinal Health at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also made changes to their positions in CAH. Cyrus J. Lawrence LLC acquired a new position in Cardinal Health during the fourth quarter worth about $26,000. Promus Capital LLC purchased a new stake in shares of Cardinal Health during the 4th quarter worth approximately $30,000. Bellwether Advisors LLC acquired a new stake in shares of Cardinal Health in the 4th quarter worth approximately $32,000. Lee Danner & Bass Inc. purchased a new position in Cardinal Health in the 4th quarter valued at approximately $35,000. Finally, Itau Unibanco Holding S.A. acquired a new position in Cardinal Health during the fourth quarter worth $36,000. 87.17% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several analysts have weighed in on CAH shares. Bank of America upped their target price on Cardinal Health from $150.00 to $155.00 and gave the company a "buy" rating in a report on Friday, April 11th. Jefferies Financial Group raised shares of Cardinal Health from a "hold" rating to a "buy" rating and increased their price objective for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. JPMorgan Chase & Co. lifted their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 4th. StockNews.com raised shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a report on Monday, May 5th. Finally, Morgan Stanley lifted their price objective on Cardinal Health from $142.00 to $166.00 and gave the stock an "overweight" rating in a research report on Monday, May 5th. Four analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $146.43.
Get Our Latest Analysis on CAH
Cardinal Health Stock Up 0.7 %
Shares of Cardinal Health stock opened at $148.36 on Friday. The firm has a market cap of $35.41 billion, a PE ratio of 27.68, a P/E/G ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $154.07. The business's fifty day moving average is $134.65 and its two-hundred day moving average is $126.40.
Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The firm had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. During the same period last year, the company earned $2.08 EPS. The firm's quarterly revenue was up .0% on a year-over-year basis. Equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be given a dividend of $0.5107 per share. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $2.04 annualized dividend and a yield of 1.38%. Cardinal Health's dividend payout ratio is 31.51%.
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
